@neurofixpharma.com
Neurofix mission is to discover and develop molecules for the treatment of pathologies of the central nervous system.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Neurofix Pharma is a Spanish biotechnology company founded by experienced scientists and executives. They focus on developing therapies for neurological conditions and have products in various stages of clinical and preclinical development. One of their notable products is NFX88, a groundbreaking drug designed to alleviate the pain experienced by individuals with spinal cord injuries and improve their quality of life.
NFX88 has successfully completed its phase IIA clinical trial and offers a pioneering alternative to current treatments. Since its establishment in 2015, Neurofix Pharma has received support and recognition from various institutions, including awards such as 'Best NEOTEC Company,' 'Innovative SME,' and 'Horizon 2020 Excellence' seal from the EU. They have also garnered investments from influential investors, including the Matutes Family Office.
With its exceptional safety profile and promising efficacy results, NFX88 represents a significant advancement in the treatment of neuropathic pain caused by spinal cord injuries, aiming to significantly enhance the lives of patients
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories